atorvastatin has been researched along with Carcinoma, Small Cell Lung in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Arand, J; Byers, LA; Cam, LL; Cao, S; Coles, GL; Contrepois, K; Cristea, S; Drainas, AP; Gershkovitz, M; He, A; Hornburg, D; Kim, JW; Sage, J; Sen, T; Snyder, MP; Williamson, SC | 1 |
1 other study(ies) available for atorvastatin and Carcinoma, Small Cell Lung
Article | Year |
---|---|
The MEK5-ERK5 Kinase Axis Controls Lipid Metabolism in Small-Cell Lung Cancer.
Topics: Animals; Atorvastatin; Cell Line, Tumor; Cell Survival; Cholesterol; Gene Knockdown Techniques; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Metabolism; Lipidomics; Lung Neoplasms; MAP Kinase Kinase 5; MAP Kinase Signaling System; Mevalonic Acid; Mice; Mitogen-Activated Protein Kinase 7; RNA-Seq; Small Cell Lung Carcinoma; Xenograft Model Antitumor Assays | 2020 |